The death rate from hypertensive kidney disease (high blood pressure-related kidney disease) increased by 48% in the U.S. over the past 25 years, with continued differences across demographic groups, according to preliminary ...
Sep 5, 2025
0
0
Few people with high blood pressure were using salt substitutes, even though they are a simple and effective way to lower sodium intake and manage blood pressure, according to preliminary research presented at the American ...
Sep 4, 2025
0
0
Some sugar substitutes may come with unexpected consequences for long-term brain health, according to a study published in Neurology. The study examined seven low- and no-calorie sweeteners and found that people who consumed ...
Sep 3, 2025
0
216
Pregnancy complications such as preeclampsia and preterm birth often arise during the late stage of pregnancy. However, researchers have primarily relied on placental cells from early pregnancy to study these conditions, ...
Sep 3, 2025
0
0
They have been promoted as a remedy for anxiety and sleeplessness, with celebrities and influencers swearing by their calming effects. Weighted blankets—heavy throws filled with glass beads or plastic pellets—have gone ...
Sep 3, 2025
0
20
People with learning disabilities progress faster to severe type 2 diabetes and are at greater risk of dying from their condition than people without these disabilities, suggests research published in the journal BMJ Open ...
Sep 2, 2025
0
0
An international team has created the first comprehensive reference measurements for blood vessel stiffness in healthy young people, a step that could give pediatric and adolescent clinics a multi-decade head start in spotting ...
Sep 2, 2025
0
1
New groundbreaking results from a clinical trial reinforce the critical importance of personalized medicine in hypertension care.
Sep 2, 2025
0
0
Adolescents who lose teeth due to decay or trauma are 42% more likely to be bullied, according to new collaborative research from the University of Sydney and the University of Melbourne.
Sep 2, 2025
0
0
Among individuals with cardiovascular disease or high cardiovascular risk and uncontrolled hypertension on multiple anti-hypertensive agents, a single subcutaneous dose of zilebesiran 300 mg led to a 5-mmHg reduction in systolic ...
Sep 1, 2025
0
0
